Overview A Study of AMD11070 in HIV-infected Patients Carrying X4-tropic Virus Status: Completed Trial end date: 2010-04-01 Target enrollment: Participant gender: Summary The purpose of this study is to determine the safety and activity of AMD11070 in HIV-infected patients carrying X4-tropic virus. Phase: Phase 1 Details Lead Sponsor: Genzyme, a Sanofi Company